Corticosteroid therapy is practically mandatory in the following condition.

Questions 145

ATI RN

ATI RN Test Bank

Pharmacology CNS Drugs Quizlet Questions

Question 1 of 5

Corticosteroid therapy is practically mandatory in the following condition.

Correct Answer: B

Rationale: The correct answer is B) Renal transplant. Corticosteroid therapy is practically mandatory in renal transplant patients due to its immunosuppressive properties. After a renal transplant, the body's immune system may recognize the new kidney as a foreign object and mount an immune response to reject it. Corticosteroids help suppress this immune response, preventing rejection and prolonging the life of the transplanted kidney. Option A) Septic shock: Corticosteroids are not typically used as a first-line treatment for septic shock. The mainstay of treatment for septic shock involves antibiotics and supportive care. Option C) Rheumatoid arthritis: While corticosteroids may be used in the treatment of rheumatoid arthritis to reduce inflammation and pain, they are not considered mandatory in all cases. There are other medications and treatment modalities available for managing rheumatoid arthritis. Option D) Ulcerative colitis: Corticosteroids are commonly used in the treatment of ulcerative colitis to reduce inflammation in the colon. However, they are not considered mandatory in all cases of ulcerative colitis and may be reserved for more severe or refractory cases. Educational context: Understanding the role of corticosteroids in different medical conditions is crucial for healthcare professionals, especially in pharmacology. Knowing when corticosteroid therapy is mandatory, as in the case of renal transplant patients, can help ensure optimal patient outcomes and prevent complications. By differentiating between conditions where corticosteroids are necessary and where they are not, healthcare providers can make informed treatment decisions based on the specific needs of each patient.

Question 2 of 5

In the treatment of chronic inflammatory diseases, the most important limitation of aspirin is

Correct Answer: C

Rationale: In the treatment of chronic inflammatory diseases, aspirin's most significant limitation is gastric mucosal damage (Option C). This is because aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes, leading to a decrease in prostaglandin synthesis. Prostaglandins play a crucial role in maintaining the integrity of the gastric mucosa by regulating blood flow and promoting mucus production. Inhibition of prostaglandins by aspirin can disrupt the protective barrier of the stomach lining, increasing the risk of gastric ulcers and gastrointestinal bleeding. Option A (Acid-base and electrolyte disturbances) is not the most important limitation of aspirin in the treatment of chronic inflammatory diseases. While aspirin can cause acid-base and electrolyte disturbances, these are generally less common and severe compared to gastric mucosal damage. Option B (Hypersensitivity and idiosyncratic reactions) is a potential adverse effect of aspirin but is not its most important limitation in the context of treating chronic inflammatory diseases. Hypersensitivity reactions, including asthma exacerbations and anaphylaxis, are more common in individuals with a known aspirin allergy. Option D (Salicylism) refers to aspirin toxicity, which can occur with high doses and is characterized by symptoms such as tinnitus, dizziness, and respiratory alkalosis. While salicylism is a concern, it is typically associated with acute overdose rather than the chronic use of aspirin for inflammatory conditions. In an educational context, understanding the limitations of aspirin is crucial for healthcare professionals to make informed decisions when prescribing NSAIDs for chronic inflammatory diseases. Emphasizing the risk of gastric mucosal damage highlights the need for monitoring patients for gastrointestinal symptoms and considering gastroprotective strategies, such as co-prescribing proton pump inhibitors, to mitigate this potential adverse effect.

Question 3 of 5

Among the rheumatoid arthritis disease-modifying drugs, fastest symptom relief is obtained with

Correct Answer: D

Rationale: In the context of rheumatoid arthritis (RA) treatment, Methotrexate is considered the cornerstone disease-modifying antirheumatic drug (DMARD) due to its efficacy and safety profile. Methotrexate works by suppressing the immune system and reducing inflammation associated with RA, leading to symptom relief and slowing down disease progression. It is known for providing faster relief compared to other DMARDs like Auranofin, Penicillamine, and Sulfasalazine. Auranofin is a gold-containing compound that is less commonly used today due to its side effects and less potent efficacy compared to Methotrexate. Penicillamine, an older DMARD, has been largely replaced by newer, more effective drugs like Methotrexate. Sulfasalazine, while effective for some RA patients, usually takes longer to show significant symptom improvement compared to Methotrexate. Educationally, understanding the differences in onset of action and efficacy among DMARDs is crucial for healthcare professionals managing RA patients. Knowing that Methotrexate offers faster symptom relief can help guide treatment decisions and improve patient outcomes by initiating appropriate therapy promptly. It also underscores the importance of evidence-based practice in selecting the most suitable medications for RA management.

Question 4 of 5

Gold in rheumatoid arthritis

Correct Answer: B

Rationale: In the context of treating rheumatoid arthritis, the correct answer is B) Can reduce the concentrations of rheumatoid factor. Gold compounds, such as aurothiomalate and auranofin, were historically used to treat rheumatoid arthritis. These medications were believed to reduce rheumatoid factor levels, which are antibodies commonly found in the blood of individuals with rheumatoid arthritis. By reducing these antibodies, gold compounds were thought to help alleviate symptoms and slow disease progression. Option A) Can cause regression of degenerative lesions of this disease is incorrect because gold compounds do not typically cause regression of degenerative lesions in rheumatoid arthritis. They are more focused on managing symptoms rather than reversing structural damage. Option C) Does not halt the progress of the disease is incorrect as gold compounds were believed to have some disease-modifying effects, although they are not considered first-line treatments due to their side effect profile and the availability of more effective medications. Option D) Is employed as first-line therapy is incorrect because gold compounds are not commonly used as first-line therapy for rheumatoid arthritis anymore. They have been largely replaced by other medications such as disease-modifying antirheumatic drugs (DMARDs) and biologics due to their more favorable risk-benefit profiles. Educationally, this question highlights the historical context of rheumatoid arthritis treatment and the evolution of pharmacological management strategies. Understanding the mechanisms and limitations of different drug classes is crucial for healthcare professionals to make informed decisions when treating patients with rheumatoid arthritis.

Question 5 of 5

Which of the following drugs is correctly associated with its site of action and maximal diuretic efficacy?

Correct Answer: A

Rationale: In this Pharmacology CNS Drugs Quizlet question, the correct answer is A) Thiazides acting in the distal convoluted tubule with a maximal diuretic efficacy of 10% of filtered Na+ excreted. Thiazides work by inhibiting the Na+/Cl- symporter in the distal convoluted tubule, leading to decreased sodium reabsorption and subsequent water excretion. Option B) Spironolactone is a potassium-sparing diuretic that acts in the collecting duct and inhibits aldosterone receptors, not in the proximal convoluted tubule as stated. Option C) Bumetanide acts in the thick ascending limb, not the distal convoluted tubule, and has a higher diuretic efficacy than 15%. Option D) Metolazone acts in the early distal convoluted tubule, not the collecting tubule as indicated, and has a higher diuretic efficacy than 2%. Educationally, understanding the site of action and maximal diuretic efficacy of diuretics is crucial for pharmacology students, as it impacts their clinical application and potential side effects. This knowledge aids in selecting the most appropriate diuretic for specific conditions and understanding their mechanisms of action in treating various disorders related to fluid balance.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions